A Study to Validate & Improve an Automated Image Analysis Algorithm to

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06084715` - The INSTITUT Study
Terminated	`NCT03028129` - Prevention of Tuberculosis in Prisons	Phase 4
Not yet recruiting	`NCT06253715` - Shortened Regimen for Drug-susceptible TB in Children	Phase 3
Withdrawn	`NCT03862248` - Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More	Phase 3
Completed	`NCT03271567` - Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
Completed	`NCT03199313` - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid	Phase 1
Active, not recruiting	`NCT04919239` - Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)	Phase 2
Active, not recruiting	`NCT03251196` - TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
Recruiting	`NCT05926466` - BTZ-043 Dose Evaluation in Combination and Selection	Phase 2
Recruiting	`NCT04752592` - Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB	N/A
Completed	`NCT04874948` - Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment	Phase 1
Not yet recruiting	`NCT04968886` - TuBerculosis Viability Interregional Study and Agreement on Biological Tests
Not yet recruiting	`NCT04485156` - Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)	Phase 3
Active, not recruiting	`NCT02715271` - Study of TB Lesions Obtained in Therapeutical Surgery
Completed	`NCT01364324` - Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Active, not recruiting	`NCT04179500` - A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Volunteers	Phase 2
Completed	`NCT04938596` - Airborne Preventive Measures to Reduce New TB Infections in Household Contacts	N/A
Recruiting	`NCT05455112` - Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis	Phase 2
Completed	`NCT03044158` - GeneXpert Performance Evaluation for Linkage to Tuberculosis Care	N/A
Withdrawn	`NCT03941496` - Azacytidine During Anti-tuberculosis Therapy	Phase 1/Phase 2

NCT number	NCT05899400
Study type	Observational
Source	Diascopic, LLC
Contact
Status	Completed
Phase
Start date	September 15, 2019
Completion date	December 31, 2022

A Study to Validate and Improve an Automated Image Analysis Algorithm to Detect Tuberculosis in Sputum Smear Slides

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms